Dorsey & Whitney Trust CO LLC Increases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Dorsey & Whitney Trust CO LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,800 shares of the exchange traded fund’s stock after buying an additional 600 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in SPDR S&P Biotech ETF were worth $252,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the stock. Intellectus Partners LLC raised its holdings in SPDR S&P Biotech ETF by 4.0% in the 4th quarter. Intellectus Partners LLC now owns 11,164 shares of the exchange traded fund’s stock worth $1,005,000 after purchasing an additional 425 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in SPDR S&P Biotech ETF by 6.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 81,438 shares of the exchange traded fund’s stock worth $7,334,000 after purchasing an additional 4,823 shares in the last quarter. Bank Julius Baer & Co. Ltd Zurich raised its holdings in SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 13,154 shares of the exchange traded fund’s stock worth $1,307,000 after purchasing an additional 487 shares in the last quarter. LHM Inc. raised its holdings in SPDR S&P Biotech ETF by 29.5% in the 4th quarter. LHM Inc. now owns 123,988 shares of the exchange traded fund’s stock worth $11,166,000 after purchasing an additional 28,226 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth $55,529,000.

SPDR S&P Biotech ETF Trading Down 0.1 %

Shares of NYSEARCA XBI opened at $86.17 on Wednesday. The firm has a fifty day simple moving average of $90.34 and a two-hundred day simple moving average of $95.08. The firm has a market capitalization of $5.68 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.